BioNTech SE SEC filings BNTX

BioNTech SE has 589 filings in SEC EDGAR's recent list, going back to Jun 19, 2019. Its latest annual report, Form 20-F, was filed on Mar 10, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 3, 2026. The company's fiscal year ends on December 31.

BioNTech SE SEC filings
Form Description Filed Period
4 Insider transaction Oct 9, 2026 Oct 8, 2026
4 Insider transaction Oct 7, 2026 Oct 7, 2026
4 Insider transaction Oct 6, 2026 Oct 5, 2026
4 Insider transaction Oct 2, 2026 Oct 1, 2026
4 Insider transaction Sep 30, 2026 Sep 29, 2026
4 Insider transaction Sep 28, 2026 Sep 25, 2026
4 Insider transaction Sep 24, 2026 Sep 23, 2026
4 Insider transaction Sep 22, 2026 Sep 21, 2026
4 Insider transaction Sep 18, 2026 Sep 17, 2026
4 Insider transaction Sep 16, 2026 Sep 15, 2026
4 Insider transaction Sep 14, 2026 Sep 11, 2026
4 Insider transaction Sep 11, 2026 Sep 10, 2026
4 Insider transaction Sep 9, 2026 Sep 8, 2026
4 Insider transaction Sep 8, 2026 Sep 3, 2026
144 Notice of proposed sale Sep 3, 2026 —
3 Initial insider ownership Jun 26, 2026 Jun 26, 2026
3 Initial insider ownership Jun 26, 2026 Jun 26, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2026 —
4 Insider transaction May 13, 2026 May 12, 2026
4 Insider transaction May 13, 2026 May 12, 2026
4 Insider transaction May 13, 2026 May 12, 2026
4 Insider transaction May 13, 2026 May 12, 2026
4 Insider transaction May 13, 2026 May 12, 2026
144 Notice of proposed sale May 12, 2026 —
4 Insider transaction Apr 23, 2026 Apr 22, 2026
3/A Form 3/a Apr 13, 2026 Mar 18, 2026
3 Initial insider ownership Mar 25, 2026 Mar 18, 2026
3 Initial insider ownership Mar 25, 2026 Mar 18, 2026
3 Initial insider ownership Mar 25, 2026 Mar 18, 2026
3 Initial insider ownership Mar 25, 2026 Mar 18, 2026
3 Initial insider ownership Mar 25, 2026 Mar 18, 2026
3 Initial insider ownership Mar 25, 2026 Mar 18, 2026
3 Initial insider ownership Mar 25, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
144 Notice of proposed sale Mar 11, 2026 —
144 Notice of proposed sale Feb 12, 2026 —
144 Notice of proposed sale Nov 28, 2025 —
144 Notice of proposed sale Nov 13, 2025 —
144 Notice of proposed sale Nov 5, 2025 —
144 Notice of proposed sale Sep 5, 2025 —
144 Notice of proposed sale Aug 15, 2025 —
144 Notice of proposed sale Aug 15, 2025 —
144/A Filing Jun 4, 2025 —
144 Notice of proposed sale Jun 4, 2025 —
144 Notice of proposed sale Jun 2, 2025 —
144 Notice of proposed sale May 28, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 13, 2025 —
144 Notice of proposed sale May 7, 2025 —
144 Notice of proposed sale Feb 27, 2025 —
144 Notice of proposed sale Feb 20, 2025 —
144 Notice of proposed sale Feb 20, 2025 —
144 Notice of proposed sale Dec 13, 2024 —
144 Notice of proposed sale Dec 11, 2024 —
144 Notice of proposed sale Dec 9, 2024 —
144 Notice of proposed sale Dec 6, 2024 —
144 Notice of proposed sale Nov 27, 2024 —
144 Notice of proposed sale Nov 26, 2024 —
144 Notice of proposed sale Nov 25, 2024 —
144 Notice of proposed sale Nov 15, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 13, 2024 —
144 Notice of proposed sale Nov 12, 2024 —
144 Notice of proposed sale Oct 16, 2024 —
144 Notice of proposed sale Oct 15, 2024 —
144 Notice of proposed sale Oct 11, 2024 —
144 Notice of proposed sale Oct 10, 2024 —
144 Notice of proposed sale Oct 9, 2024 —
144 Notice of proposed sale Oct 8, 2024 —
144 Notice of proposed sale Oct 7, 2024 —
144 Notice of proposed sale Oct 4, 2024 —
144 Notice of proposed sale Oct 3, 2024 —
144 Notice of proposed sale Oct 2, 2024 —
144 Notice of proposed sale Oct 1, 2024 —
144 Notice of proposed sale Sep 30, 2024 —
144 Notice of proposed sale Sep 27, 2024 —
144 Notice of proposed sale Sep 25, 2024 —
144 Notice of proposed sale Sep 18, 2024 —
144 Notice of proposed sale Sep 17, 2024 —
144 Notice of proposed sale Sep 16, 2024 —
144 Notice of proposed sale Sep 16, 2024 —
144 Notice of proposed sale Sep 13, 2024 —
144 Notice of proposed sale Feb 28, 2024 —
SC 13D Ownership over 5% (active) Feb 21, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 7, 2024 —
144 Notice of proposed sale Jan 4, 2024 —
144/A Filing Oct 10, 2023 —
144 Notice of proposed sale Sep 29, 2023 —
144 Notice of proposed sale Sep 29, 2023 —
144/A Filing Aug 14, 2023 —
144 Notice of proposed sale Jun 29, 2023 —
144 Notice of proposed sale Jun 28, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 22, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2022 —
SC 13G/A Amended ownership over 5% (passive) Feb 11, 2022 —
SC 13G/A Amended ownership over 5% (passive) Feb 16, 2021 —
SC 13G/A Amended ownership over 5% (passive) Feb 16, 2021 —
SC 13G/A Amended ownership over 5% (passive) Feb 16, 2021 —
SC 13G Ownership over 5% (passive) Feb 14, 2020 —
SC 13G Ownership over 5% (passive) Feb 13, 2020 —
SC 13G Ownership over 5% (passive) Feb 12, 2020 —
SC 13D Ownership over 5% (active) Jan 23, 2020 —

Showing 108 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
BNTX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Germany
Headquarters
Mainz, Germany
SEC filer status
Large accelerated filer
SEC CIK
1776985

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.